A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study

Not Applicable

Completed

• Conditions: Cachexia; Cancer

• Registration Number: NCT01419145
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-08-16
• Study First Submitted QC: 2011-08-16
• Study First Posted: 2011-08-17
• Study Start: 2011-10
• Primary Completion: 2014-08
• Study Completion: 2014-11
• Status Verified: 2017-06
• Last Update Submitted: 2017-06-15
• Last Update Posted: 2017-06-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Feasibility of recruitment and retention	12 weeks	The aim of this study is to investigate the feasibility of the multimodal intervention for cancer cachexia by assessing; enrolment rate, compliance with study intervention, contamination-rate in the control group with respect to any of the interventions.

Trial Locations

Locations (3)

Oslo University Hospital Ullevål; 🇳🇴 Oslo, Norway

St Olavs Hospital; 🇳🇴 Trondheim, Norway

University of Edinburgh; 🇬🇧 Edinburgh, United Kingdom